Synergistic killing of leukemia U937 Cells by low-intensity ultrasound and doxorubicin

Toru Yoshida*, Loreto B. Feril, Takashi Kondo, Qing Li Zhao, Ryohei Ogawa, Kazuhiro Tsukada

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

Potential clinical use of ultrasound in enhancing the effects of anticancer drugs in the treatment of cancers has been highlighted in previous reports. Increased uptake of drugs by the cancer cells due to ultrasound has been suggested as a mechanism. However, the precise mechanism of the enhancement has not yet been elucidated. Here, the combined effects of low-intensity pulsed ultrasound and doxorubicin (DOX) on killing (loss of viability and apoptosis) of U937 cells, and the involved mechanism were investigated. The synergistic enhancement in cell killing and additive enhancement in induction of apoptosis were observed above 0.3 W/cm2. No enhancement was observed at intensity of 0.2 W/cm2 in cell killing and induction of apoptosis. The mechanisms of the enhancement are 1) Increase in incorporation of the DOX by ultrasound involved with sonoporation. 2) Enhancement of the cavitation by DOX. 3) Cavitation is required for the enhancement of the DOX effects.

Original languageEnglish
Title of host publication6th International Symposium on Therapeutic Ultrasound
Pages479-483
Number of pages5
DOIs
StatePublished - 2007
Event6TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND - Oxford, United Kingdom
Duration: 2007/08/302007/09/02

Publication series

NameAIP Conference Proceedings
Volume911
ISSN (Print)0094-243X
ISSN (Electronic)1551-7616

Conference

Conference6TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND
Country/TerritoryUnited Kingdom
CityOxford
Period2007/08/302007/09/02

Keywords

  • Apoptosis
  • Doxorubicin
  • Low-intensity ultrasound

ASJC Scopus subject areas

  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Synergistic killing of leukemia U937 Cells by low-intensity ultrasound and doxorubicin'. Together they form a unique fingerprint.

Cite this